Rapport Therapeutics, Inc. Common StockRAPPNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

4 analysts·Low coverage

100%

Rating Distribution

Strong Buy

00%

Buy

4100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 55% higher.

Bear Case

$40.00

+47%

Consensus

$42.33

+55%

Bull Case

$44.00

+61%

Price Range4 analysts

Low

Consensus

High

$40.00

$44.00

Current Target

Current Price

$27.30

Upside to Target

$15.03

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-3.52(6 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev—

EPS—

FY2029

Rev—

EPS—

Earnings Surprises

Beat rate:83%(5/6 quarters)

Avg surprise:-16.1%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 2, 2026Wells Fargo

Rapport Therapeutics initiated with an Overweight at Wells Fargo

Target:$43.00

+61.6%from $26.61

Dec 19, 2025Wells Fargo

Goldman Sachs Reiterates Buy Rating on Rapport Therapeutics (RAPP)

Target:$51.00

+72.1%from $29.64

Dec 9, 2025H.C. Wainwright

Rapport Therapeutics price target raised to $40 from $34 at H.C. Wainwright

Target:$40.00

+32.6%from $30.16

Sep 16, 2025Truist Financial

Rapport Therapeutics initiated with a Buy at Truist

Target:$44.00

+77.1%from $24.85

Jul 2, 2024Jefferies

Rapport Therapeutics initiated with a Buy at Jefferies

Target:$35.00

+37.6%from $25.44

Jul 2, 2024Stifel Nicolaus

Stifel Starts Rapport Therapeutics (RAPP) at Buy

Target:$35.00

+37.6%from $25.44

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance